PROVENGE WINNING PITCH

At launch, Provenge was the first and only immunotherapy for prostate cancer. This customized treatment trains the patient's T-cells to detect and destroy tumor cells. While Provenge extends life, and offers a uniquely tolerable side effect profile, the therapy struggled to gain uptake.

My art partner and I were challenged to relaunch the brand. After extensive interviews, we found Provenge helps men feel empowered. After testing and refinement of 3 concepts, our "Fighting prostate cancer is my personal battle” went into production (seen at top).